Transcend Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Sell |
2,412
-1,135
| -32% | -$78.3K | 0.01% | 592 |
|
|
2025
Q1 | $246K | Sell |
3,547
-105
| -3% | -$7.29K | 0.02% | 516 |
|
|
2024
Q4 | $314K | Sell |
3,652
-867
| -19% | -$74.6K | 0.02% | 431 |
|
|
2024
Q3 | $538K | Buy |
4,519
+1,321
| +41% | +$157K | 0.04% | 373 |
|
|
2024
Q2 | $457K | Buy |
3,198
+501
| +19% | +$71.5K | 0.03% | 381 |
|
|
2024
Q1 | $346K | Sell |
2,697
-905
| -25% | -$116K | 0.03% | 387 |
|
|
2023
Q4 | $373K | Sell |
3,602
-458
| -11% | -$47.4K | 0.03% | 349 |
|
|
2023
Q3 | $369K | Buy |
4,060
+858
| +27% | +$78K | 0.04% | 341 |
|
|
2023
Q2 | $259K | Buy |
3,202
+300
| +10% | +$24.3K | 0.02% | 404 |
|
|
2023
Q1 | $231K | Buy |
+2,902
| New | +$231K | 0.02% | 418 |
|